PharmaClik Login 
Home - McKesson Canada
Advancing Health Outcomes for All
Touching Virtually Every Aspect of Health
As a diversified healthcare leader, our solutions help patients access life-changing therapies, whether because we deliver a third of all medications in Canada, consult with patients at our pharmacies, or partner with members and stakeholders of the healthcare industry. We do all this and much more as we pursue our purpose to advance health outcomes for all.
Advancing Health Outcomes for All
Touching Virtually Every Aspect of Health
As a diversified healthcare leader, our solutions help patients access life-changing therapies, whether because we deliver a third of all medications in Canada, consult with patients at our pharmacies, or partner with members and stakeholders of the healthcare industry. We do all this and much more as we pursue our purpose to advance health outcomes for all.
Distribution
Biopharma & Provider Solutions
Retail Pharmacy Solutions
Automation Technology Solutions
SPOTLIGHT ON:
Rare Disease Drugs In Canada: Considerations For Equitable Access
Ensuring comprehensive, timely and equitable access to medication for rare diseases is a significant public policy priority for the Government of Canada. McKesson Canada is proud to contribute to the public policy conversation around this national strategy, building on its experience with patient support programs, pharmaceutical distribution, and specialty pharmacy services.
SPOTLIGHT ON:
Rare Disease Drugs In Canada: Considerations For Equitable Access
Ensuring comprehensive, timely and equitable access to medication for rare diseases is a significant public policy priority for the Government of Canada. McKesson Canada is proud to contribute to the public policy conversation around this national strategy, building on its experience with patient support programs, pharmaceutical distribution, and specialty pharmacy services.
Princess Margaret Cancer Centre and McKesson Canada partner to elevate best practices for cancer treatment in community infusion clinics
Toronto, ON (October 24, 2024) – Princess Margaret Cancer Centre, part of University Health Network in Toronto, has partnered with McKesson Canada to implement best practices for the delivery of high-quality care to cancer patients who receive treatment in the organization’s network of community infusion clinics.
As part of their cancer journey, some oncology patients use independent, community-based infusion clinics, which can offer a wider variety of treatment options for patients and provide access to leading edge medicines. This partnership will benefit patients and ensure they receive the same level of seamless, high-quality care at McKesson Canada’s INVIVA clinics as they do at Princess Margaret.
To date, formal relationships between community infusion clinics and cancer centres have been limited. Before launching the partnership, Princess Margaret conducted a comprehensive inspection of McKesson Canada’s oncology services, which are accredited by Accreditation Canada, including its infusion clinics and pharmacy at its central Toronto location. With the partnership now in place, Princess Margaret and McKesson Canada look forward to working together to align quality standards.
About Princess Margaret Cancer Centre
The Princess Margaret Cancer Centre has gained an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres, is part of University Health Network in Toronto. For more information: www.theprincessmargaret.ca
About McKesson Canada
McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver products, services and insights to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.
For media inquiries:
The Princess Margaret Cancer Centre
Marina Jimenez
McKesson Canada
Sybil Millar
McKesson Corporation Announces Sale of Rexall and Well.ca Businesses to Birch Hill Equity Partners
IRVING, Texas, [September 5, 2024]—McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm.
In line with McKesson Corporation’s enterprise strategy, this transaction enables McKesson to further focus and prioritize investments to grow its oncology and biopharma services platforms. McKesson Corporation remains fully committed to and confident in the strength of our Canadian distribution and biopharma businesses, delivering solutions to ensure the delivery of better health outcomes.
“This transaction marks an important milestone aligned to our enterprise strategy, advancing our strategic priorities, further streamlining our business and prioritizing investment in our growth areas of oncology and biopharma services,” said Brian Tyler, Chief Executive Officer, McKesson. “We remain fully committed to and confident in the strength of our Canadian distribution and biopharma businesses. I am proud of the accomplishments that Rexall and Well.ca have achieved with McKesson and I have every confidence that both businesses will flourish under Birch Hill’s ownership.”
Birch Hill Equity Partners is a mid-market Canadian private equity firm with more than 30 years of experience supporting Canadian companies on driving growth initiatives. Through this transaction, we believe Rexall and Well.ca will have a partner committed to investing the resources and capital needed to build on the businesses’ strong foundation, while providing services to Canadians from more locations, to address critical healthcare needs. McKesson Canada continues to see value in Rexall and Well.ca and intends to remain a wholesale distribution supplier to each business.
McKesson Canada will continue to own and operate Rexall and Well.ca until transaction close, which is subject to customary closing conditions, including necessary regulatory clearances.
Cautionary Statements
Except for historical information, statements in this press release related to McKesson’s proposed disposition of the Rexall and Well.ca operations and assets in Canada constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties that could cause actual results to differ materially from those in those statements. It is not possible to identify all such risks and uncertainties. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the company undertakes no obligation to publicly update forward-looking statements. We encourage investors to read the important risk factors described in the company’s most recent Form 10-K filed with the Securities and Exchange Commission. These risk factors include, but are not limited to: we might be adversely impacted by delays or other difficulties with divestitures such as the transactions described in this press release; we from time to time record significant charges from impairment to goodwill, intangibles and other assets or investments; we might be adversely impacted by events outside of our control, such as widespread public health issues, natural disasters, political events and other catastrophic events.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable.Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.
Investor Contact
Rachel Rodriguez
469-260-0556
Rachel.Rodriguez@McKesson.com
Media Contact
Media@mckesson.ca
Rexall Launches First Pharmacist Care Walk-In Clinic in Barrie
Local Rexall® pharmacists can now assess and provide required care for common illnesses, addressing immediate healthcare needs and promoting preventive care.
BARRIE, ON, April 19, 2024 /CNW/ - Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for minor illnesses, as well as services including chronic disease management, vaccinations, men's and women's health, and point-of-care testing, among others.
Rexall's Pharmacist Care Walk-In Clinic is dedicated to enhancing accessible healthcare by increasing the value pharmacists provide to patients, especially when it comes to preventative healthcare and chronic condition management. We are taking a collaborative approach to work with primary care physicians throughout the Barrie community. Additionally, we offer virtual physician care services when needed, further improving access to comprehensive care for our patients.
"We are pleased to announce the opening of our Pharmacist Care Walk-In Clinic, which will enhance healthcare access in the Barrie community by empowering local pharmacists to assess and provide necessary care for immediate health concerns and improving long-term health outcomes," says Qaiser Hassan, pharmacy manager for the Barrie Rexall Pharmacist Care Walk-In Clinic. "We look forward to empowering individuals in the Barrie community to actively manage a healthy and happy lifestyle. This initiative brings us closer to strengthening the bond between healthcare providers and patients, aligning with Rexall's commitment to caring for Canadians' health, one person at a time."
Services that will be offered to patients at the Pharmacist Care Walk-In Clinic include:
• Minor illnesses (mild acne, UTI, pink eye, eczema, cold sores, seasonal allergies, etc.)
• Chronic disease management (diabetes, hypertension, etc.)
• Women's and men's health
• Travel health and vaccinations
• Point of care testing (Lipids, A1C, COVID, etc.)
• Immunization and injections
• Smoking cessation
• Prescription refills and renewals
• On-site physician virtual care
The launch event on Friday, April 19th, 2024, will feature a ribbon-cutting ceremony, guided tours of the clinic's state-of-the-art facilities, and a chance to meet the passionate healthcare professionals who will be serving the community.
For more information, please visit rexall.ca/clinic-duckworth
Rexall Barrie Pharmacy Care Walk-In Clinic Team. Photo by Stephan Potopnyk (CNW Group/Rexall Pharmacy Group ULC.)
Rexall celebrates their first Ontario pharmacy walk-in clinic opening in Barrie, Ontario. Photo by Stephan Potopnyk (CNW Group/Rexall Pharmacy Group ULC.)
About Rexall
With a dynamic history of innovation and growth dating back over a century, Rexall is a leading pharmacy retailer in Canada, dedicated to caring for Canada's health, one person at a time. Operating approximately 400 pharmacies across Canada, Rexall's 8,000 employees provide compassionate care to patients, becoming their trusted health partners along their wellness journey.
Rexall is part of the Rexall Pharmacy Group ULC and a proud member of the global McKesson Canada Corporation family, a diversified healthcare company with deep roots in supporting patients across Canada.
For more information, visit rexall.ca. Follow us on Twitter: @RexallDrugStore, on Instagram at @RexallDrugStoreOfficial, and @RexallCareNetwork and on Facebook at @RexallDrugStore
SOURCE Rexall Pharmacy Group ULC.
For further information: Media Contact, media@rexall.ca
